Todd D Tillmanns MD
Gynecologic Cancer
Professor, Division Chief and Program Director of Gynecologic Oncology University of Tennessee Health Science Center College of Medicine and West Cancer Center Research Institute
Join to view full profile
7945 Wolf River BlvdGermantown, TN 38138
Phone+1 901-683-0055
Fax+1 901-922-6701
Dr. Tillmanns is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Oklahoma Health Sciences CenterResidency, Obstetrics and Gynecology, 2000 - 2003
Medical College of Wisconsin Affiliated HospitalsResidency, Obstetrics and Gynecology, 1996 - 2000
Creighton University School of MedicineClass of 1996- University of Oklahoma Health Sciences CenterFellowship, Gynecologic Oncology
Certifications & Licensure
AR State Medical License 2012 - 2027
MS State Medical License 2003 - 2027
TN State Medical License 2003 - 2027
OK State Medical License 2000 - 2004
WI State Medical License 1997 - 2001
MN State Medical License 1998 - 1998
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2013-2014, 2016-2017
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2009-2012
Clinical Trials
Publications & Presentations
PubMed
- Plain language summary of results from the DUO-E study: durvalumab given with or without olaparib in patients with advanced endometrial cancer.Shannon N Westin, Kathleen Moore, Hye Sook Chon, Jung-Yun Lee, Jessica Thomes Pepin
Future Oncology. 2026-04-01 - 14 citationsAdvanced endometrial cancer-The next generation of treatment: A society of gynecologic oncology journal club clinical commentary.Todd Tillmanns, Amal Masri, Chelsea Stewart, Dana Chase, Anthony Karnezis
Gynecologic Oncology Reports. 2024-10-01 - 284 citationsDurvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase I...Shannon N Westin, Kathleen Moore, Hye Sook Chon, Jung-Yun Lee, Jessica Thomes Pepin
Journal of Clinical Oncology. 2024-01-20
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: